新闻动态
ubpbio/Idarubicin HCl/F8101/25 mg
2025-06-24
Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL. Idarubicin is developed in an attempt to reduce the cardiotoxicity and enhance the therapeutic efficacy of the parent compound. Idarubicin HCl is an inhibitor of Topo II α and an apoptosis inducer.
Additional Information
Idarubicin HCl |
4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl |
F8101 |
25 mg |
533.95 Da |
N/A |
Synthetic |
Powder |
N/A |
>99% by HPLC and NMR |
Eligible for room temperature shipping. Store at -20°C upon receiving; protect from air and light |
PDF Datasheet |
N/A |
N/A |
Room temperature shipping |
1. Fukushima T, et al. (1993). Int. J. Hematol. 57: 121-130.2. Belaud-Rotureau MA, et al. (2000). Leukemia. 14: 1266-1275.3. Orlandi P, et al. (2005) J Chemother. 17(6): 663-667.4. Colburn DE, et al. (2004) Hematology. 9(3): 217-221. |
Details
Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL. Idarubicin is developed in an attempt to reduce the cardiotoxicity and enhance the therapeutic efficacy of the parent compound. Idarubicin HCl is an inhibitor of Topo II α and an apoptosis inducer.How to useIdarubicin HCL was used at 0.1 nM - 10 nM in various cell-based in vitro assays.
本文链接: https://www.ebiomall.cn/b459-ubpbio/info-1549185820.html
免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
相关文章
2020-07-06
2020-07-19
2020-07-31
2020-08-09
2020-09-22
2020-10-01
2020-10-14
2020-10-24
2017-10-21


▍
官网分类
▍
品牌问答